Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Enoxaparin | 5 | 2022 | 391 | 0.980 |
Why?
|
Acute Coronary Syndrome | 6 | 2023 | 2194 | 0.970 |
Why?
|
Atrial Function, Left | 5 | 2019 | 188 | 0.940 |
Why?
|
Heart Atria | 7 | 2019 | 1361 | 0.770 |
Why?
|
Benzamides | 5 | 2019 | 1379 | 0.750 |
Why?
|
Echocardiography | 14 | 2024 | 5047 | 0.740 |
Why?
|
Venous Thromboembolism | 5 | 2022 | 1883 | 0.740 |
Why?
|
Cardiomyopathy, Alcoholic | 1 | 2017 | 6 | 0.600 |
Why?
|
Rotation | 1 | 2017 | 517 | 0.510 |
Why?
|
Heart Conduction System | 4 | 2017 | 1009 | 0.500 |
Why?
|
Embolism, Air | 1 | 2016 | 110 | 0.500 |
Why?
|
Pyridines | 5 | 2019 | 2894 | 0.490 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2017 | 2145 | 0.480 |
Why?
|
Arrhythmias, Cardiac | 5 | 2018 | 2258 | 0.470 |
Why?
|
Mitral Valve Stenosis | 2 | 2017 | 342 | 0.470 |
Why?
|
Coronary Vessels | 6 | 2018 | 3124 | 0.450 |
Why?
|
Coronary Thrombosis | 2 | 2013 | 440 | 0.440 |
Why?
|
Myocardial Infarction | 11 | 2023 | 11519 | 0.440 |
Why?
|
Anticoagulants | 8 | 2022 | 4852 | 0.420 |
Why?
|
Atrial Appendage | 2 | 2013 | 285 | 0.390 |
Why?
|
Ventricular Function, Left | 5 | 2024 | 3941 | 0.380 |
Why?
|
Nicotinic Agonists | 1 | 2013 | 265 | 0.380 |
Why?
|
Quinoxalines | 1 | 2013 | 297 | 0.380 |
Why?
|
Benzazepines | 1 | 2013 | 308 | 0.380 |
Why?
|
Atherosclerosis | 4 | 2022 | 3433 | 0.340 |
Why?
|
Echocardiography, Doppler | 6 | 2017 | 898 | 0.340 |
Why?
|
Coronary Artery Disease | 7 | 2019 | 6568 | 0.330 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1323 | 0.320 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1805 | 0.300 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 2080 | 0.300 |
Why?
|
Atrial Fibrillation | 5 | 2018 | 5176 | 0.290 |
Why?
|
Coronary Angiography | 11 | 2018 | 4541 | 0.270 |
Why?
|
Nephrotic Syndrome | 1 | 2010 | 381 | 0.270 |
Why?
|
Electrocardiography | 9 | 2017 | 6412 | 0.250 |
Why?
|
Heart Ventricles | 5 | 2018 | 3841 | 0.240 |
Why?
|
Thrombosis | 3 | 2014 | 2957 | 0.240 |
Why?
|
Hemorrhage | 5 | 2019 | 3467 | 0.230 |
Why?
|
Apolipoprotein A-I | 2 | 2023 | 305 | 0.230 |
Why?
|
Asymptomatic Diseases | 2 | 2018 | 590 | 0.220 |
Why?
|
Pericardial Effusion | 2 | 2016 | 246 | 0.220 |
Why?
|
Mitral Valve | 3 | 2018 | 1475 | 0.210 |
Why?
|
Stroke Volume | 4 | 2024 | 5622 | 0.210 |
Why?
|
Stents | 5 | 2018 | 3195 | 0.210 |
Why?
|
Fatty Liver | 3 | 2014 | 809 | 0.210 |
Why?
|
Heart Failure | 4 | 2024 | 11879 | 0.200 |
Why?
|
Aortic Valve | 3 | 2017 | 1970 | 0.190 |
Why?
|
Coronary Aneurysm | 2 | 2014 | 234 | 0.180 |
Why?
|
Diagnosis, Differential | 9 | 2018 | 13014 | 0.180 |
Why?
|
Warfarin | 2 | 2018 | 1493 | 0.170 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2020 | 208 | 0.160 |
Why?
|
Humans | 60 | 2024 | 768166 | 0.160 |
Why?
|
Leukocytosis | 1 | 2019 | 251 | 0.150 |
Why?
|
Inferior Wall Myocardial Infarction | 1 | 2018 | 10 | 0.150 |
Why?
|
Cholesterol | 3 | 2023 | 2914 | 0.150 |
Why?
|
Pregnancy Trimesters | 1 | 2019 | 197 | 0.150 |
Why?
|
Heart Valve Diseases | 2 | 2017 | 1030 | 0.150 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2024 | 1065 | 0.140 |
Why?
|
Retinal Artery | 1 | 2018 | 109 | 0.140 |
Why?
|
Retinal Artery Occlusion | 1 | 2018 | 83 | 0.140 |
Why?
|
Turkey | 5 | 2017 | 256 | 0.140 |
Why?
|
Stroke | 5 | 2019 | 9755 | 0.130 |
Why?
|
Coronary Stenosis | 2 | 2013 | 802 | 0.130 |
Why?
|
Rheumatic Heart Disease | 1 | 2017 | 164 | 0.130 |
Why?
|
Vitamin K | 1 | 2018 | 314 | 0.130 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2227 | 0.130 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1820 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 308 | 0.120 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2018 | 615 | 0.120 |
Why?
|
Male | 39 | 2024 | 364719 | 0.120 |
Why?
|
Pericarditis | 1 | 2016 | 136 | 0.120 |
Why?
|
Brugada Syndrome | 2 | 2014 | 98 | 0.120 |
Why?
|
Embolism | 1 | 2018 | 401 | 0.120 |
Why?
|
Reference Values | 2 | 2019 | 4938 | 0.110 |
Why?
|
Heart Neoplasms | 1 | 2017 | 374 | 0.110 |
Why?
|
Eosinophils | 1 | 2018 | 952 | 0.110 |
Why?
|
Female | 34 | 2024 | 397192 | 0.110 |
Why?
|
Ventricular Pressure | 1 | 2013 | 210 | 0.100 |
Why?
|
Ethinyl Estradiol | 1 | 2013 | 114 | 0.100 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 552 | 0.100 |
Why?
|
Risk Factors | 11 | 2022 | 74944 | 0.100 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2019 | 2763 | 0.100 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2018 | 646 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2018 | 1027 | 0.100 |
Why?
|
Postpartum Period | 1 | 2019 | 1198 | 0.100 |
Why?
|
Postoperative Care | 1 | 2018 | 1480 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1551 | 0.090 |
Why?
|
Androstenes | 1 | 2013 | 177 | 0.090 |
Why?
|
Proportional Hazards Models | 4 | 2019 | 12543 | 0.090 |
Why?
|
Aortic Aneurysm | 1 | 2016 | 649 | 0.090 |
Why?
|
Recurrence | 4 | 2018 | 8509 | 0.090 |
Why?
|
Middle Aged | 28 | 2024 | 223492 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6316 | 0.090 |
Why?
|
Creatinine | 1 | 2016 | 1918 | 0.090 |
Why?
|
Monitoring, Ambulatory | 1 | 2014 | 358 | 0.090 |
Why?
|
Aged | 16 | 2024 | 171504 | 0.090 |
Why?
|
Adult | 21 | 2019 | 223646 | 0.090 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2013 | 477 | 0.090 |
Why?
|
Heart Diseases | 2 | 2014 | 2819 | 0.090 |
Why?
|
Cardiovascular System | 1 | 2018 | 841 | 0.090 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 560 | 0.090 |
Why?
|
Papillary Muscles | 1 | 2011 | 192 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 366 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2018 | 1162 | 0.090 |
Why?
|
Hospitalization | 2 | 2022 | 10840 | 0.090 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2014 | 383 | 0.080 |
Why?
|
Cardiology | 2 | 2019 | 1702 | 0.080 |
Why?
|
Case-Control Studies | 6 | 2017 | 22291 | 0.080 |
Why?
|
Coronary Restenosis | 1 | 2012 | 396 | 0.080 |
Why?
|
Aneurysm, False | 1 | 2011 | 263 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 877 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7064 | 0.080 |
Why?
|
Predictive Value of Tests | 8 | 2018 | 15454 | 0.080 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2013 | 1724 | 0.080 |
Why?
|
Angina Pectoris | 1 | 2012 | 957 | 0.080 |
Why?
|
Anemia | 1 | 2018 | 1514 | 0.080 |
Why?
|
Calcinosis | 1 | 2017 | 1481 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 2017 | 1946 | 0.070 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2012 | 359 | 0.070 |
Why?
|
Coronary Circulation | 1 | 2014 | 1617 | 0.070 |
Why?
|
Pericardium | 1 | 2012 | 679 | 0.070 |
Why?
|
Coronary Occlusion | 1 | 2010 | 306 | 0.070 |
Why?
|
User-Computer Interface | 1 | 2013 | 1407 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2191 | 0.070 |
Why?
|
Risk | 1 | 2018 | 9613 | 0.070 |
Why?
|
Educational Measurement | 1 | 2013 | 1260 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3135 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2018 | 3573 | 0.060 |
Why?
|
Survival Analysis | 1 | 2018 | 10101 | 0.060 |
Why?
|
Exercise Test | 1 | 2013 | 2186 | 0.060 |
Why?
|
Time Factors | 5 | 2019 | 40218 | 0.060 |
Why?
|
Comorbidity | 2 | 2018 | 10590 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 704 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2043 | 0.060 |
Why?
|
Heart Function Tests | 2 | 2017 | 317 | 0.060 |
Why?
|
Shock, Cardiogenic | 1 | 2010 | 711 | 0.060 |
Why?
|
Tomography, Optical Coherence | 3 | 2014 | 2957 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2012 | 1424 | 0.060 |
Why?
|
Aortic Valve Stenosis | 1 | 2017 | 2032 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39348 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10399 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1614 | 0.060 |
Why?
|
Alcoholism | 1 | 2015 | 1980 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 13053 | 0.060 |
Why?
|
Prospective Studies | 5 | 2024 | 54926 | 0.060 |
Why?
|
Blood Platelets | 1 | 2014 | 2479 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2024 | 65371 | 0.050 |
Why?
|
Amyloidosis | 1 | 2010 | 878 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1398 | 0.050 |
Why?
|
Smoking Cessation | 1 | 2013 | 2085 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59629 | 0.050 |
Why?
|
Neprilysin | 1 | 2024 | 487 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3110 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 1 | 2011 | 1415 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2016 | 3781 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2012 | 3329 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3252 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2100 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20760 | 0.040 |
Why?
|
Pregnancy | 2 | 2019 | 30256 | 0.040 |
Why?
|
Software | 1 | 2013 | 4478 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 2 | 2018 | 1096 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12077 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3436 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2023 | 682 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10873 | 0.040 |
Why?
|
Heart | 1 | 2011 | 4446 | 0.040 |
Why?
|
Aorta | 2 | 2017 | 2045 | 0.040 |
Why?
|
Laxatives | 1 | 2018 | 95 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 879 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 916 | 0.040 |
Why?
|
ROC Curve | 2 | 2017 | 3628 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2023 | 1474 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1609 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 893 | 0.030 |
Why?
|
Capillaries | 1 | 2018 | 755 | 0.030 |
Why?
|
Ultrasonography, Interventional | 2 | 2014 | 1523 | 0.030 |
Why?
|
Young Adult | 4 | 2018 | 60066 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2017 | 582 | 0.030 |
Why?
|
Dietary Fiber | 1 | 2018 | 767 | 0.030 |
Why?
|
Risk Assessment | 4 | 2018 | 24315 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9263 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15662 | 0.030 |
Why?
|
Liver | 3 | 2014 | 7577 | 0.030 |
Why?
|
Ventricular Function, Right | 1 | 2018 | 629 | 0.030 |
Why?
|
Lung | 1 | 2012 | 10099 | 0.030 |
Why?
|
Heart Rate | 2 | 2017 | 4214 | 0.030 |
Why?
|
Peripartum Period | 1 | 2014 | 137 | 0.030 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2014 | 234 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1643 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2403 | 0.020 |
Why?
|
Hemoglobins | 1 | 2018 | 1531 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2014 | 606 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2018 | 1070 | 0.020 |
Why?
|
Brachial Artery | 1 | 2013 | 373 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2014 | 591 | 0.020 |
Why?
|
Manometry | 1 | 2014 | 459 | 0.020 |
Why?
|
Diastole | 1 | 2014 | 785 | 0.020 |
Why?
|
Radiography | 2 | 2014 | 6983 | 0.020 |
Why?
|
Medication Adherence | 1 | 2023 | 2187 | 0.020 |
Why?
|
Systole | 1 | 2014 | 937 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1500 | 0.020 |
Why?
|
United States | 1 | 2018 | 73039 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2014 | 1375 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2011 | 353 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2016 | 81762 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3479 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4030 | 0.020 |
Why?
|
Ultrasonography | 2 | 2014 | 6004 | 0.020 |
Why?
|
Metals | 1 | 2014 | 713 | 0.020 |
Why?
|
Dyspnea | 1 | 2017 | 1352 | 0.020 |
Why?
|
Action Potentials | 1 | 2017 | 1838 | 0.020 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2010 | 223 | 0.020 |
Why?
|
Waist Circumference | 1 | 2012 | 935 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2013 | 1525 | 0.020 |
Why?
|
Drug-Eluting Stents | 1 | 2014 | 681 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13290 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13676 | 0.020 |
Why?
|
Cohort Studies | 3 | 2017 | 41754 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15948 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1346 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7243 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2125 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2862 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2012 | 1622 | 0.020 |
Why?
|
Critical Illness | 1 | 2019 | 2756 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6211 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20227 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1892 | 0.020 |
Why?
|
Emergencies | 1 | 2012 | 1221 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2013 | 873 | 0.020 |
Why?
|
Prognosis | 2 | 2017 | 30010 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26379 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6526 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12465 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8375 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6793 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9669 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3986 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2726 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3533 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3251 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10632 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2013 | 5349 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14729 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4063 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18412 | 0.010 |
Why?
|
Smoking | 1 | 2013 | 9092 | 0.010 |
Why?
|
Adolescent | 1 | 2013 | 89169 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2011 | 21206 | 0.000 |
Why?
|